2016 Accomplishments Report
Greetings and welcome to the 2016 Accomplishments Report of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
I believe 2016 was another remarkable year for our cancer program as we continued to make an impact in changing the landscape of cancer research and treatment while pursuing our shared vision of creating a cancer-free world, one person and one discovery at a time.
Our more than 340 researchers, who represent 12 of the 15 colleges at Ohio State, have collectively increased our National Cancer Institute grant funding over the past decade by 40 percent—to now more than $54 million—and they continue to publish their discoveries in prestigious scientific journals.
2016 was the second full year of operation for our new James Cancer Hospital and Solove Research Institute, which opened in December 2014 as the nation’s third-largest cancer hospital, with 21 floors, 1.1 million square feet and 308 beds. We have now reached 98 percent bed occupancy in this transformational facility, which integrates cancer research and care more closely than ever. In 2016 we admitted 13,780 inpatients and recorded more than 391,000 outpatient visits, increases of nearly 9 percent over the previous year.
This Accomplishments Report highlights our many achievements and activities of 2016, including:
- Peer-reviewed research studies that have furthered global knowledge of cancer in its many forms;
- Large grants that our medical scientists received for cancer research;
- Our success in recruiting some of the most brilliant minds in cancer research and care;
- Prominent awards earned by our medical scientists and programs;
- Far-reaching initiatives and projects;
- The continuing success of Pelotonia, an annual grassroots bicycle tour that in 2016 raised a record $24.1 million and boosted the event’s eight-year overall total to more than $130 million for cancer research at Ohio State.
As the OSUCCC – James has an ever-greater impact around the world, we have become a destination for cancer care, receiving patients from all 50 states and 36 countries. This report reflects our continued success in helping the many patients and families who turn to us for help and hope.
Michael A. Caligiuri, MD
Director, The Ohio State University Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute
John L. Marakas Nationwide Insurance
Enterprise Foundation Chair in Cancer Research
President-Elect, American Association for Cancer Research